Description
Clinical research is a key asset of the Institute, and the Directorate of Advanced Clinical Research and Innovation, an area of the Scientific Directorate that works in close synergy with the Health Directorate, is the engine that drives the development of sponsored and independent clinical research, integrating care activities, clinical research, and therapeutic innovation and diagnostics.
Through an interdisciplinary vision, the Directorate promotes, coordinates and monitors the quality of clinical research and strengthens collaborations with national and international partners.
The Directorate of Advanced Clinical Research and Innovation reports to:
Clinical research activities are carried out by the highly qualified medical, nursing and technical staff and clinical researchers from the different areas of the Institute through specific and continuous training courses and in close collaboration with the research coordinators and professionals from the diagnostic-therapeutic platforms. This organizational model fosters a shared, integrated, efficient approach geared toward scientific excellence.
Mission
The mission of the Directorate is to strengthen and accelerate clinical research, fostering the continuous evolution of diagnostic-therapeutic pathways and theintroduction of innovative therapies also through the synergy between pre-clinical and clinical research, creating the conditions for the development of new drugs, therapeutic combinations and new diagnostic-technological assets.
Management is also committed to ensuring alignment with the standards required by IRCCS and OECI accreditations, contributing to the Institute’s positioning as a cancer center of excellence.
Responsibility
Management:
- promotes, plans, coordinates and monitors theactivation of clinical trials, both industry-sponsored and independentstudies sponsored by the Institute;
- defines procedures, objectives and priorities, ensuring the quality of processes according to international best practices and with continuous training of the Institute’s investigators;
- Maintains relationships with pharmaceutical companies, CROs, regulatory bodies and academic partners;
- supports clinical researchers;
- guides the establishment of institutional SOPs (Standard Operating Procedures);
- contributes to the feasibility review of protocols and strategic planning of enrollment activities, fostering the scientific and economic growth of the Institute.
Contact
The Directorate is the point of contact for sponsors, industrial partners, institutions and personnel involved in clinical research:
- Active clinical trials: ufficio.trials@ircc.it
- Activation of new clinical trials: clinicalstudy.startup@ircc.it
- Collaborations and partnerships (responsible Lawyer Paola Baggetta): paola.baggetta@ircc.it – contratti@ircc.it
- TTO – Technology Transfer Office (head James Hughes, PhD) tto@ircc.it
